Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
The Journal of Steroid Biochemistry and Molecular Biology|November 19, 2003
Steroid sulfatase and estrogen sulfotransferase in normal human tissue and breast carcinomaTakashi Suzuki, Yasuhiro Miki, Taisuke Nakata, et al.
The Journal of Steroid Biochemistry and Molecular Biology|November 19, 2003
Role of steroid sulfatase in local formation of estrogen in post-menopausal breast cancer patientsTaisuke Nakata, Shigemitsu Takashima, Yukimasa Shiotsu, et al.
Investigational New Drugs|December 17, 2013
A phase II trial of a selective c-Met inhibitor tivantinib (ARQ 197) monotherapy as a second- or third-line therapy in the patients with metastatic gastric cancerYoon-Koo Kang, Kei Muro, Min-Hee Ryu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 3, 2024
Carrier-free mRNA vaccine induces robust immunity against SARS-CoV-2 in mice and non-human primates without systemic reactogenicitySaed Abbasi, Miki Matsui-Masai, Fumihiko Yasui, et al.
Cancer Science|February 7, 2016
Preclinical and first-in-human phase I studies of KW-2450, an oral tyrosine kinase inhibitor with insulin-like growth factor receptor-1/insulin receptor selectivityGary K Schwartz, Mark A Dickson, Patricia M LoRusso, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2007
A novel FLT3 inhibitor FI-700 selectively suppresses the growth of leukemia cells with FLT3 mutationsHitoshi Kiyoi, Yukimasa Shiotsu, Kazutaka Ozeki, et al.
Bioorganic & Medicinal Chemistry Letters|October 7, 2008
Novel and orally active 5-(1,3,4-oxadiazol-2-yl)pyrimidine derivatives as selective FLT3 inhibitorsHiroshi Ishida, Shoichi Isami, Tsutomu Matsumura, et al.
The Prostate|January 24, 2008
A neutralizing anti-fibroblast growth factor (FGF) 8 monoclonal antibody shows anti-tumor activity against FGF8b-expressing LNCaP xenografts in androgen-dependent and -independent conditionsKumiko Maruyama-Takahashi, Naoki Shimada, Teruyoshi Imada, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 18, 2010
Defucosylated humanized anti-CCR4 monoclonal antibody KW-0761 as a novel immunotherapeutic agent for adult T-cell leukemia/lymphomaToshihiko Ishii, Takashi Ishida, Atae Utsunomiya, et al.
Cancer Chemotherapy and Pharmacology|April 23, 2014
A phase 1 and dose-finding study of LY2523355 (litronesib), an Eg5 inhibitor, in Japanese patients with advanced solid tumorsHiroshi Wakui, Noboru Yamamoto, Satoru Kitazono, et al.
Pageof 5